U-BX TECHNOLOGY LTD (UBXG)

KYG9161K1040 - Common Stock

3.45  +0.24 (+7.48%)

Fundamental Rating

2

Overall UBXG gets a fundamental rating of 2 out of 10. We evaluated UBXG against 83 industry peers in the IT Services industry. While UBXG seems to be doing ok healthwise, there are quite some concerns on its profitability. UBXG is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

UBXG had negative earnings in the past year.
In the past year UBXG has reported a negative cash flow from operations.
UBXG had negative earnings in 4 of the past 5 years.
In multiple years UBXG reported negative operating cash flow during the last 5 years.

1.2 Ratios

UBXG has a worse Return On Assets (-5.75%) than 65.43% of its industry peers.
UBXG has a Return On Equity of -6.96%. This is comparable to the rest of the industry: UBXG outperforms 45.68% of its industry peers.
Industry RankSector Rank
ROA -5.75%
ROE -6.96%
ROIC N/A
ROA(3y)-0.14%
ROA(5y)-1.01%
ROE(3y)2.82%
ROE(5y)-7.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 1.57%, UBXG is not doing good in the industry: 96.30% of the companies in the same industry are doing better.
UBXG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for UBXG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

UBXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UBXG remains at a similar level compared to 1 year ago.
Compared to 1 year ago, UBXG has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.76 indicates that UBXG is not in any danger for bankruptcy at the moment.
UBXG has a Altman-Z score of 6.76. This is amongst the best in the industry. UBXG outperforms 80.25% of its industry peers.
UBXG has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of UBXG (0.05) is better than 76.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 6.76
ROIC/WACCN/A
WACC10.11%

2.3 Liquidity

UBXG has a Current Ratio of 5.75. This indicates that UBXG is financially healthy and has no problem in meeting its short term obligations.
UBXG has a Current ratio of 5.75. This is amongst the best in the industry. UBXG outperforms 95.06% of its industry peers.
A Quick Ratio of 5.75 indicates that UBXG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.75, UBXG belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.75
Quick Ratio 5.75

More info and screens

0

3. Growth

3.1 Past

The earnings per share for UBXG have decreased strongly by -579.21% in the last year.
Looking at the last year, UBXG shows a very negative growth in Revenue. The Revenue has decreased by -46.36% in the last year.
UBXG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.66% yearly.
EPS 1Y (TTM)-579.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-488.72%
Revenue 1Y (TTM)-46.36%
Revenue growth 3Y-10.66%
Revenue growth 5YN/A
Sales Q2Q%-45.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UBXG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UBXG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

U-BX TECHNOLOGY LTD

NASDAQ:UBXG (12/23/2024, 3:05:43 PM)

3.45

+0.24 (+7.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner ChangeN/A
Ins Owners39.04%
Ins Owner ChangeN/A
Market Cap6.42M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS43.49
BVpS7.46
TBVpS7.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -6.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.57%
FCFM N/A
ROA(3y)-0.14%
ROA(5y)-1.01%
ROE(3y)2.82%
ROE(5y)-7.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
F-Score2
Asset Turnover4.82
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 174.93%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.75
Quick Ratio 5.75
Altman-Z 6.76
F-Score2
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)156.74%
Cap/Depr(5y)154.22%
Cap/Sales(3y)0.01%
Cap/Sales(5y)0.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-579.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-488.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-46.36%
Revenue growth 3Y-10.66%
Revenue growth 5YN/A
Sales Q2Q%-45.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-310.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-377.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-377.87%
OCF growth 3YN/A
OCF growth 5YN/A